Table:
begin	end	state
1	26	cytoplasmic
27	47	transmembrane
48	53	non-cytoplasmic
54	73	transmembrane
74	106	cytoplasmic
107	129	transmembrane
130	134	non-cytoplasmic
135	153	transmembrane
154	163	cytoplasmic
164	187	transmembrane
188	207	non-cytoplasmic
208	230	transmembrane
231	249	cytoplasmic
250	270	transmembrane
271	290	non-cytoplasmic
291	313	transmembrane
314	344	cytoplasmic
345	362	transmembrane
363	367	non-cytoplasmic
368	389	transmembrane
390	409	cytoplasmic
410	432	transmembrane
433	437	non-cytoplasmic
438	457	transmembrane
458	473	cytoplasmic

Input:
>Pf6N2E2_5459 FitnessBrowser__pseudo6_N2E2:Pf6N2E2_5459
MAVGNHLPHGETAQGGPLKRELGERHIRLMALGACIGVGLFLGSAKAIEMAGPAIMLSYI
IGGLAILVIMRALGEMAVHNPVAGSFSRYAQDYLGPLAGFLTGWNYWFLWLVTCVAEITA
VAVYMGIWFPDVPRWIWALAALVSMGSINLIAVKAFGEFEFWFALIKIVTIIAMVIGGVG
IIAFGFGNDGVALGISNLWTHGGFMPNGVQGVLMSLQMVMFAYLGVEMIGLTAGEAKNPQ
KTIPNAIGSVFWRILLFYVGALFVILSIYPWNEIGTQGSPFVMTFERLGIKTAAGIINFV
VITAALSSCNGGIFSTGRMLYSLAQNGQAPAGFATTSANGVPRRALLLSIAALLLGVLLN
YLVPEKVFVWVTSIATFGAIWTWVMILLAQLKFRKSLSASERAALKYRMWLYPVSSYLAL
AFLVLVVGLMAYFPDTRVALYVGPAFLVLLTVLFYVFKLQPTGETHGSVRSVS

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server